Erratum: Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: Results of an exploratory phase II study of 41 patients (Rheumatology (2007) vol. 46 (1460-1465) 10.1093/rheumatology/kem172);Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: Results of an exploratory phase II study of 41 patients

Rheumatology

Volumn 46, Issue 9, 2007, Pages 1460-1465

  Mayerhoefer, Marius E ^a   Kramer, J ^b   Breitenseher, M J ^a,c   Norden, C ^d   Vakil Adli, A ^e   Hofmann, S ^f   Meizer, R ^g   Siedentop, H ^d   Landsiedl, F ^g   Aigner, N ^g  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Institute of CT and MRI Diagnostics Schillerpark   (Austria)

^c Institute of Radiology   (Austria)

^d BAYER PHARMA AG   (Germany)

^e Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^f LKH Stolzalpe ^*  (Austria)

^g ORTHOPAEDIC HOSPITAL SPEISING   (Austria)

Author keywords

Bone marrow cells; Drug therapy; Knee; MRI

Indexed keywords

ILOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; TRAMADOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANALGESIA; ARTICLE; BONE MARROW DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; JOINT SWELLING; KNEE PAIN; LEG ISCHEMIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION;

EID: 34548271672     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken183     Document Type: Erratum

References (36)

1. Breitenseher MJ, Kramer J, Mayerhoefer ME, Aigner N, Hofmann S. Differential diagnosis of bone marrow edema of the knee joint. Radiologe 2006;46:46-64.
2. Hofmann S, Engel A, Neuhold A, Leder K, Kramer J, Plenk H Jr. Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression. J Bone Joint Surg Br 1993;75:210-6.
3. Zanetti M, Bruder E, Romero J, Hodler J. Bone marrow edema pattern in osteoarthritic knees: Correlation between MR imaging and histologic findings. Radiology 2000;215:835-40.
4. Plank H Jr, Hofmann S, Eschberger J et al. Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop 1997;334:73-84.
5. Guerra JJ, Steinberg ME. Distinguishing transient ostooporosis from avascular necrosis of the hip. J Bone Joint Surg Am 1995;77:616-24.
6. Froberg PK, Braunstein EM, Buckwalter KA. Osteonecrosis, transient osteoporosis, and transient bone marrow edema: Current concepts. Radiol Clin North Am 1996;34:273-91.
7. Krause R, Glas K, Schulz A, Gradinger R. The transitory bone marrow edema syndrome of the hip. Z Orthop Ihre Grenzgeb 2002;140:286-96.
8. Hofmann S. The painful bone marrow edema syndrome of the hip joint. Wien Klin Wochenschr 2005;117:111-20.
9. Turner DA, Templeton AC, Selzer PM, Rossenberg AG, Petasnick JP. Femoral capital osteonecrosis: MR finding of diffuse marrow abnormalities without focal lesions. Radiology 1989;171:135-40.
10. Hayes CW, Balkissoon AA. Magnetic resonance imaging of the musculoskeletal system. II. The hip. Clin Orthop Relat Res 1996;322:297-309.
11. Radke S, Rader C, Kenn W, Kirschner S, Walther M, Eulert J. Transient marrow edema syndrome of the hip: Results after core decompression. A prospective MRI-controlled study in 22 padents. Arch Orthop Trauma Surg 2003;123:223-7.
12. Aigner N, Petje G, Schneider W et al. Bone marrow edema syndrome of the femoral head: Treatment with the prostacyclin analogue iloprost vs core decompression: An MRI-controlled study. Wien Klin Wochenschr 2005;117:130-5.
13. Felson DT, McLaughlin S, Goggins J, Gale D, Nevitt MC, Felson DT. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003;139:330-6.
14. Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG. Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med 1987;106:444-50.
15. Boos S, Sigmund G, Huhle P, Nurbakhsch I. Magnetic tomography of so-called transient osteoporosis. Primary diagnosis and follow-up after treatment. Rofo 1993;158:201-6.
16. Hofmann S, Schneider W, Breitenseher M, Urban M, Plenk H Jr. Transient osteoporosis as a special reversible form of femur head necrosis. Orthopade 2000;29:411-9.
17. Koo KH, Ahn IO, Kim R et al. Bone marrow edema and associated pain in early stage osteonecrosis of the fermoral head: Prospective study with serial MR images. Radiology 1999;213:715-22.
18. Crespo E, Sala D, Crespo R, Silvestro A. Transient osteoporosis. Acta Orthop Belg 2001;67:330-7.
19. Grimm J, Higer HP, Banning R, Meairs S. MRI of transient osteoporosis of the hip. Arch Orthop Trauma Surg 1991;110:98-102.
20. Wilson AJ, Murphy WA, Hardy DC, Totty WG. Transient osteoporosis: transient bone marrow edema? Radiology 1998;167:757-60.
21. Venda Berg BE, Malghem JJ, Labaisse MA, Noel HM, Maldague BE. MR imaging of avascular mecrosis and transient marrow edema of the femoral head. Radiographics 1993;13:501-20.
22. Calvo E, Fernandez-Yruegas D, Alvarez L. Core decompression shortens the duration of pain in-bone marrow oedema syndrome. Int Orthop 2000;24:88-91.
23. Disch AC, Matziolis G, Parka C. The management of necrosis-associated and idiopathic bone-marrow oedema of this proximal femur by intravenous iloprost. J Bone Joint Surg Br 2005;87:560-4.
24. Meizer R, Radda C, Stolz G et al. MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr 2005;117:278-88.
25. Hildebrand M, Pfeffer M, Mahler M, Stake T, Windt-Hanke F, Schutt A. Oral Iloprost in healthy volunteers. Eicosanoids 1991;4:149-54.
26. Smillie IS. Larson score. In: Smillie IS, ed. Diseases of the knee joint. Edinburgh, London: Churchill Livingstone, 1974;28-31.
27. Mayerhoefer ME, Braitenseher M, Hofmann S et al. Computer-assisted quantitative analysis of bone marrow edema of the knee: Initial experience with a new method. AJR Am J Roentgenol 2004;182:1399-403.
28. Aigner N, Petje G, Steinboeck G, Schneider W, Krasny C, Landsiedi F. Treatment of bone-marrow oadema of the talus with the prostacyclin analogue iloprost. An MRI-oontrolled investigation of a now method. J Bone Joint Surg Br 2001;83:855-8.
29. Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemis, and extracorporeal circulation procedures. Drugs 1992;43:889-924.
30. Koo KH, Jeong ST, Jones JP Jr. Borderline necrosis of the femoral head. Clin Orthop Relat Res 1999;358:158-65.
31. Atsumi T, Kuroki Y. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 1992;277:22-30.
32. Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 1993;44:243-8.
33. Boahme MW, Gao, IK, Norden C, Lemmel EM. Decrease in circulating endothelial call adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: Preliminary results. Rheumatol Int 2006;26:340-7.
34. Gao IK, Scholz P, Boehme MW, Norden C, Lemmel EM. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: Cytokine modulation, safety, and clinical effects. Rhaumatol Int 2002;22;45-51.
35. Yamamoto T, Bullough PG. Spontaneous osteonecrosis of the knee: The result of subchondral insufficiency fracture. J Bone Joint Surg Am 2000;82:858-66.
36. Narvaez JA, Narvaez J, De Lama E, Sanchez A. Spontaneous osteonecrosis of the knee associated with tibial plateau and femoral condos insuffiency stress fracture. Eur Radiol 2003;13:1843-8.